Company registration number 03515608 (England and Wales)
BESWICK HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
BESWICK HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
D J Hudson
B J Jenkins
Secretary
G M Gatty
Company number
03515608
Registered office
128 Buckingham Palace Road
London
United Kingdom
SW1W 9SA
Auditor
Azets Audit Services
2nd Floor
Regis House
45 King William Street
London
United Kingdom
EC4R 9AN
BESWICK HEALTHCARE LIMITED
CONTENTS
Page
Directors' report
1
Independent auditor's report
2 - 4
Profit and loss account
5
Balance sheet
6
Statement of changes in equity
7
Notes to the financial statements
8 - 14
BESWICK HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 1 -

The directors present their annual report and financial statements for the year ended 30 September 2025.

Principal activities

The principal activity of the company continued to be that of property management. The company is a Special Purpose Vehicle for the development and management of a Private Finance Initiative project. It is not anticipated that the principal activity will change during the coming year.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

D J Hudson
B J Jenkins
Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
B J Jenkins
Director
3 July 2026
BESWICK HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BESWICK HEALTHCARE LIMITED
- 2 -
Opinion

We have audited the financial statements of Beswick Healthcare Limited (the 'company') for the year ended 30 September 2025 which comprise the profit and loss account, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 30 September 2025 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- the information given in the directors' r eport for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the directors' report has been prepared in accordance with applicable legal requirements.

BESWICK HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BESWICK HEALTHCARE LIMITED (CONTINUED)
- 3 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identifie d material misstatements in the directors' r eport. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit; or

- the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report and from the requirement to prepare a strategic report.

Responsibilities of directors

As explained more fully in the directors' r esponsibilities s tatement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

BESWICK HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BESWICK HEALTHCARE LIMITED (CONTINUED)
- 4 -

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.

We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

- Enquiry of management and those charged with governance around actual and potential litigation and claims as well as actual, suspected and alleged fraud;

- Assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the company through enquiry and inspection;

- Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;

- Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of potential bias.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Rebecca Boys (Senior Statutory Auditor)
For and on behalf of Azets Audit Services, Statutory Auditor
Chartered Accountants
2nd Floor
Regis House
45 King William Street
London
EC4R 9AN
14 July 2026
BESWICK HEALTHCARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 5 -
2025
2024
£
£
Turnover
639,737
627,787
Administrative expenses
(269,756)
(353,509)
Operating profit
369,981
274,278
Interest receivable and similar income
-
0
8,834
Interest payable and similar expenses
(75,563)
(82,725)
Profit before taxation
294,418
200,387
Tax on profit
(94,378)
-
0
Profit for the financial year
200,040
200,387

The profit and loss account has been prepared on the basis that all operations are continuing operations.

BESWICK HEALTHCARE LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2025
30 September 2025
- 6 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
1,202,447
1,211,969
Current assets
Debtors
6
66,418
487,063
Cash at bank and in hand
159,501
440,176
225,919
927,239
Creditors: amounts falling due within one year
7
(166,218)
(1,276,122)
Net current assets/(liabilities)
59,701
(348,883)
Total assets less current liabilities
1,262,148
863,086
Creditors: amounts falling due after more than one year
8
(1,049,022)
-
0
Net assets
213,126
863,086
Capital and reserves
Called up share capital
170,000
170,000
Profit and loss reserves
43,126
693,086
Total equity
213,126
863,086

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 3 July 2026 and are signed on its behalf by:
B J Jenkins
Director
Company registration number 03515608 (England and Wales)
BESWICK HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 7 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 October 2023
170,000
492,699
662,699
Year ended 30 September 2024:
Profit and total comprehensive income
-
200,387
200,387
Balance at 30 September 2024
170,000
693,086
863,086
Year ended 30 September 2025:
Profit and total comprehensive income
-
200,040
200,040
Dividends
-
(850,000)
(850,000)
Balance at 30 September 2025
170,000
43,126
213,126
BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 8 -
1
Accounting policies
Company information

Beswick Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 128 Buckingham Palace Road, London, United Kingdom, SW1W 9SA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Disclosure exemption

Exemption has been taken from preparing a cash flow statement on the grounds that the company is considered to be small under the provisions of the Companies Act 2006.

Service Concession Arrangements

The company has claimed exemption under section 35.10(i) of FRS 102, from the application of paragraphs 34.12I to 34.16A for FRS 102 to service concession arrangements which were entered into before the date of transition to FRS 102. The service concession arrangement will continue to be accounted for as assets of the operator and included as part of property, plant and equipment.

1.2
Going concern

The company has long term funding in place and has a detailed financial model on which its future operations are based. The directors have considered the company’s projected income and cash flows in the short and medium term and they consider that these projections, together with available loan finance, will enable the company to trade for the foreseeable future and to meet its liabilities as they fall due. The company therefore continues to adopt the going concern basis in preparing its financial statements. true

1.3
Turnover

Turnover represents lease income and facilities management fees received in the year.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Over the period of the lease
Fixtures and fittings
10% over cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 9 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 10 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 11 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Depreciation and useful economic lives

Determine whether there are indicators of impairment of the company's tangible assets. Factors taken into consideration in reaching such a decision include the economic viability and expected future financial performance of the asset and where it is a component of a larger cash-generating unit, the viability and expected future performance of that unit.

Tangible fixed assets are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on a number of factors. In re-assessing assets lives, factors such as technological innovation, product life cycles and maintenance programmes are taken into account. Residual value assessments consider issues such as future market conditions, the remaining life of the asset and projected disposal values.

3
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
8,100
7,700
4
Employees

The average monthly number of persons employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 12 -
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 October 2024 and 30 September 2025
1,964,597
159,385
2,123,982
Depreciation and impairment
At 1 October 2024
753,879
158,134
912,013
Depreciation charged in the year
9,244
278
9,522
At 30 September 2025
763,123
158,412
921,535
Carrying amount
At 30 September 2025
1,201,474
973
1,202,447
At 30 September 2024
1,210,718
1,251
1,211,969

All fixed assets are leased to third parties.

6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
64,368
65,241
Amounts owed by group undertakings
-
0
419,229
Other debtors
2,050
2,593
66,418
487,063
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
-
0
1,197,513
Trade creditors
20,981
36,396
Corporation tax
75,898
-
0
Other taxation and social security
15,130
14,768
Other creditors
54,209
27,445
166,218
1,276,122
BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
7
Creditors: amounts falling due within one year
(Continued)
- 13 -

The bank loan was secured on the company's long leasehold property and by a fixed and floating charge over all of the remaining assets of the company, dated 13 July 1999.

The bank loan represents amounts drawn down on an available facility to develop the long leasehold property. Interest is chargeable on the loan at a fixed rate of 6.26% subject to prompt payment. The terms of the loan provide for repayment of the loan in instalments by the termination date, which is defined as 25 years after the practical completion of the development which was 4 July 2000. Repayment is by quarterly instalments and the balance of the loan is repayable by the termination date. The loan was repaid on 1 July 2025.

8
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Other borrowings
1,049,022
-
0
Creditors which fall due after five years are payable as follows:
Payable by instalments
305,324
-
Payable other than by instalments
550,000
-
855,324
-

The other borrowings loan is secured on the company's long leasehold property and by a fixed and floating charge over all of the remaining assets of the company, dated 4 July 2025.

The other borrowings represents a commerical loan from the parent company Guildhouse UK Limited. Interest is chargeable on the loan at a fixed rate of 6.5%. Repayment is by quarterly instalments and the balance of the loan is repayable 10 years from the date of issue.

9
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

BESWICK HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
9
Related party transactions
(Continued)
- 14 -

Guildhouse UK Limited

During the year the company was charged management fees of £18,792 (20 24: £18,077) by Guildhouse UK Limited, its parent company. At the balance sheet date the company was owed £nil (20 24: £419,229) to Guildhouse UK Limited as amounts owed to group undertakings.

At the balance sheet datek, the company owed £1,090,130 (2024: £nil) to Guildhouse UK Limited. The loan bears interest at 6.5% and due for repayment over 10 years. During the year, the company was charged interest totalling £17,875 (2024: £nil) from Guildhouse UK Limited.

During the year, the company paid management fees in respect of the surrender of group losses totalling £nil (2024: £13,387) to Guildhouse UK Limited, its parent company.

During the year, the company paid dividends totalling £850,000 (2024: £nil) to Guildhouse UK Limited.

Assemble Fundco 2 Limited

During the year, the company paid management fees in respect of the surrender of group losses totalling £nil (20 24: £2,318) to Assemble Fundco 2 Limited. Assemble Fundco 2 Limited is the subsidary company of Assemble Community Partnership Limited, which is a subsidary Guildhouse UK (PPP) Limited an intermediate parent company.

Assemble Fundco 1 Limited

During the year, the company paid management fees in respect of the surrender of group losses totalling £nil (2024: £96,831) by Assemble Fundco 1 Limited. Assemble Fundco 1 Limited is the subsidary company of Assemble Community Partnership Limited, which is a subsidary Guildhouse UK (PPP) Limited an intermediate parent company.

Assemble Community Partnership Limited

During the year, the company paid management fees in respect of the surrender of group losses totalling £nil (2024; £11,556) by Assemble Community Partnership Limited. Assemble Community Partnership Limited is a subsidary of Guildhouse UK Limited.

10
Parent company

The company is a wholly owned subsidiary of Guildhouse UK Limited, a company registered in England and Wales.

The results of the company are included in the consolidated financial statements of Guildhouse Holdings Limited, the parent company of Guildhouse UK Limited. The consolidated financial statements are available from Companies House, Crown Way, Cardiff, CF14 3UZ.

Mr D J Hudson, a director, is considered to be the ultimate controlling party of Guildhouse Holdings Limited.

2025-09-30 2024-10-01 false false false CCH Software CCH Accounts Production 2026.100 D J Hudson B J Jenkins G M Gatty 03515608 2024-10-01 2025-09-30 03515608 bus:Director1 2024-10-01 2025-09-30 03515608 bus:Director2 2024-10-01 2025-09-30 03515608 bus:CompanySecretary1 2024-10-01 2025-09-30 03515608 bus:RegisteredOffice 2024-10-01 2025-09-30 03515608 2025-09-30 03515608 2023-10-01 2024-09-30 03515608 core:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 03515608 core:RetainedEarningsAccumulatedLosses 2024-10-01 2025-09-30 03515608 2024-09-30 03515608 core:LandBuildings 2025-09-30 03515608 core:OtherPropertyPlantEquipment 2025-09-30 03515608 core:LandBuildings 2024-09-30 03515608 core:OtherPropertyPlantEquipment 2024-09-30 03515608 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 03515608 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 03515608 core:WithinOneYear 2025-09-30 03515608 core:WithinOneYear 2024-09-30 03515608 core:AfterOneYear 2025-09-30 03515608 core:AfterOneYear 2024-09-30 03515608 core:CurrentFinancialInstruments 2025-09-30 03515608 core:CurrentFinancialInstruments 2024-09-30 03515608 core:ShareCapital 2025-09-30 03515608 core:ShareCapital 2024-09-30 03515608 core:RetainedEarningsAccumulatedLosses 2025-09-30 03515608 core:RetainedEarningsAccumulatedLosses 2024-09-30 03515608 core:ShareCapital 2023-09-30 03515608 core:RetainedEarningsAccumulatedLosses 2023-09-30 03515608 core:LandBuildings core:LongLeaseholdAssets 2024-10-01 2025-09-30 03515608 core:FurnitureFittings 2024-10-01 2025-09-30 03515608 core:LandBuildings 2024-09-30 03515608 core:OtherPropertyPlantEquipment 2024-09-30 03515608 2024-09-30 03515608 core:LandBuildings 2024-10-01 2025-09-30 03515608 core:OtherPropertyPlantEquipment 2024-10-01 2025-09-30 03515608 core:Non-currentFinancialInstruments 2025-09-30 03515608 core:Non-currentFinancialInstruments 2024-09-30 03515608 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 03515608 bus:FRS102 2024-10-01 2025-09-30 03515608 bus:Audited 2024-10-01 2025-09-30 03515608 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP